Market Overview

Healthcare Stocks Topping The IPO Leader Boards During Q3

Share:
Healthcare Stocks Topping The IPO Leader Boards During Q3

  • According to Triad Securities, healthcare stocks "topped the IPO-performance leaderboard."
  • IPO high-flyers within the healthcare group include Global Blood Therapeutics Inc (NASDAQ: GBT), ProNAi Therapeutics Inc (NASDAQ: DNAI) and Nantkwest Inc (NASDAQ: NK).
  • During the third quarter, on average, deals opened higher by 13 percent their indicated prices, falling short of the 17 percent average in the second quarter.
  • According to Triad Securities, 40 companies saw their stocks trade for the first time on a public exchange during the third quarter. On average, deals opened higher by 13 percent than their indicated prices, marking a decrease from the 17 percent average seen in the second quarter.

    Of all the sectors, healthcare IPOs saw the strongest performance in the quarter, based on opening price versus issue price. The sector saw 15 unique IPOS with an average change indicated price to open of 26.2 percent.

    Related Link: 6 Stocks With Hot Short-Selling Activity

    A Closer Look

    As an example, Global Blood Therapeutics, a biopharmaceutical company that engages in discovering, developing and commercializing therapeutics to treat blood-based disorders, saw its shares open at $34.65, 73 percent above the expected price. The stock has seen some volatility in the weeks following its initial offering, but are still nearly 12 percent higher compared to its opening day.

    ProNai Therapeutics proved to be the second largest opening-day gainer in the quarter, as its stock opened 68.7 percent higher versus its offering price. The third largest gainer was Rapid7 Inc (NASDAQ: RPD), a provider of security data and analytics solutions and was the only company within the information technology sector to hold an IPO.

    Finally, Triad Securities noted that given ongoing commodity and global economic concerns, they are not expecting a surge in IPO activity unless already public companies issue an overall positive third quarter print. Following a seasonally quiet end of the year, there could be "pent-up demand" from both companies and investors for IPOs in early 2016, that is if the markets stabilize by the new year.

    Image Credit: Public Domain

    Posted-In: Healthcare IPO IPOAnalyst Color News Health Care Analyst Ratings Trading Ideas General Best of Benzinga

     

    Related Articles (DNAI + GBT)

    View Comments and Join the Discussion!

    Latest Ratings

    StockFirmActionPT
    VRTSBank of AmericaUpgrades
    TSCOWells FargoMaintains115.0
    USCRSidoti & Co.Maintains60.0
    JELDRBC CapitalMaintains17.0
    ASMLRBC CapitalMaintains270.0
    View the Latest Analytics Ratings
    Don't Miss Any Updates!
    News Directly in Your Inbox
    Subscribe to:
    Benzinga Trading Daily
    Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
    Market in 5 Minutes
    Everything you need to know about the market - quick & easy.
    Daily Analyst Rating
    A summary of each day’s top rating changes from sell-side analysts on the street.
    Thank You

    Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

    Pfizer's Phase 2 Study Demonstrates Safety, Tolerability and Immunogenicity of TRUMENBA® When Coadministered with Meningococcal A, C, Y and W-135 Polysaccharide Conjugate (MCV4) and Tetanus, Diphtheria and Pertussis (Tdap) Vaccines in Adolescents

    Do Your Internet Picks Match Credit Suisse's Picks?